1. Haugarvoll, Kristoffer, Toft, Mathias, Ross, Owen A, Aasly, Jan O, Farrer, Matthew J. 2007. Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway. In Neuroscience letters, 416, 299-301. doi:. https://pubmed.ncbi.nlm.nih.gov/17324517/
2. Yao, Longping, Lu, Fengfei, Koc, Sumeyye, Skutella, Thomas, Lu, Guohui. 2023. LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF-β1 in Parkinson's Disease. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303711. doi:10.1002/advs.202303711. https://pubmed.ncbi.nlm.nih.gov/37672887/
3. Turan, Serap. 2022. Osteopetrosis: Gene-based nosology and significance Dysosteosclerosis. In Bone, 167, 116615. doi:10.1016/j.bone.2022.116615. https://pubmed.ncbi.nlm.nih.gov/36402365/
4. Iida, Aritoshi, Xing, Weirong, Docx, Martine K F, Mortier, Geert, Ikegawa, Shiro. 2016. Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity. In Journal of medical genetics, 53, 568-74. doi:10.1136/jmedgenet-2016-103756. https://pubmed.ncbi.nlm.nih.gov/27055475/
5. Guo, Long, Girisha, Katta M, Iida, Aritoshi, Miyake, Noriko, Ikegawa, Shiro. 2016. Identification of a novel LRRK1 mutation in a family with osteosclerotic metaphyseal dysplasia. In Journal of human genetics, 62, 437-441. doi:10.1038/jhg.2016.136. https://pubmed.ncbi.nlm.nih.gov/27829680/
6. Snead, David M, Matyszewski, Mariusz, Dickey, Andrea M, Leschziner, Andres E, Reck-Peterson, Samara L. 2022. Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules. In Nature structural & molecular biology, 29, 1196-1207. doi:10.1038/s41594-022-00863-y. https://pubmed.ncbi.nlm.nih.gov/36510024/
7. Morimoto, Keiko, Baba, Yoshihiro, Shinohara, Hisaaki, Toyofuku, Toshihiko, Kumanogoh, Atsushi. 2016. LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. In Scientific reports, 6, 25738. doi:10.1038/srep25738. https://pubmed.ncbi.nlm.nih.gov/27166870/